关键词： 雅培 ARCHITECT
2012年12月24日讯 /生物谷BIOON/ --雅培（Abbott）第二代睾酮检测试剂盒ARCHITECT获得了FDA批准，该试剂盒有望帮助医生更精确地测量男性及女性中大范围的睾酮水平。该款试剂盒采用化学发光微粒免疫检测方法，可用于测定人血清和血浆中睾酮水平。（生物谷bioon.com）
英文原文：
Abbott has received US Food and Drug Administration clearance for its new testosterone test, ARCHITECT 2nd generation testosterone assay.
The testosterone assay is expected to help physicians to accurately measure the wide range of testosterone levels seen in men and women, according to the company.
Abbott endocrinology global scientific affairs director Frank Quinn said,"The improved assay performance means physicians will be able to obtain more reliable measurements of testosterone and use this information to help guide patient treatment decisions."
The new assay made of Abbott's ARCHITECT family of analyzers, is available in the US as well as in several European countries, Asia Pacific, Latin America, Japan, Africa, the Middle East, and India, pending country registration.
The assay is a chemiluminescent microparticle immunoassay to determine testosterone quantity in human serum and plasma.
